Pharmacy

Report Slams 340B Drug Discount ProgramA Pacific Research Institute report revealed that the 340B program is in desperate need of reform, while 340B Health refutes damaging claims.
Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
Groundbreaking gene therapies in store for hemophiliaTreatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.
How the Flu’s Severity Will Effect Healthcare SpendingThe flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
How a customized COPD care bundle is reducing readmissionsReducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.
Pfizer VP Robert Popovian Talks Value-Based ReimbursementThe impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy ChangesHow are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
Four pain management programs curbing the opioid epidemicFrom State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Five changes healthcare executives can expect in 2018The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.
New patient-centered tool could help measure value in healthcareThe Innovation and Value Initiative launched the Open-Source Value Project, creating tools that help payers, providers, and healthcare systems make informed and patient-centered decisions that produce better health outcomes.